Sunday, February 13, 2011

WHEN PROMISE OUTGROWS A CLINICAL STUDY

Positive results from fetal surgery for spina bifida were such that a study at UC San Francisco was discontinued so more could benefit. But long before faith in the surgery got to that point, the practice was limited to allow for the study. This is only one of the study’s bioethical complexities debated in Pam Belluck’s piece in the New York Times (“Risk and Reward in Utero, Feb. 12, 2001, Week in Review).


http://www.nytimes.com/2011/02/13/weekinreview/13belluck.html?_r=1&hpw


No comments:

Post a Comment